Patients with high Axl and low LC3 expression in tumors had the highest HCC recurrence (HR: 6.53; P < 0.001) and mortality rates (HR: 6.66; P < 0.001). The gene discussed is MAP1LC3A; the disease is hepatocellular carcinoma.